Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Immunol. 2008 May;8(5):380-90. doi: 10.1038/nri2304.

Molecular pathogenesis of T-cell leukaemia and lymphoma.

Author information

  • 1Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, New York 10016, USA. iannis.aifantis@med.nyu.edu

Abstract

T-cell acute lymphoblastic leukaemia (T-ALL) is induced by the transformation of T-cell progenitors and mainly occurs in children and adolescents. Although treatment outcome in patients with T-ALL has improved in recent years, patients with relapsed disease continue to have a poor prognosis. It is therefore important to understand the molecular pathways that control both the induction of transformation and the treatment of relapsed disease. In this Review, we focus on the molecular mechanisms responsible for disease induction and maintenance. We also compare the physiological progression of T-cell differentiation with T-cell transformation, highlighting the close relationship between these two processes. Finally, we discuss potential new therapies that target oncogenic pathways in T-ALL.

PMID:
18421304
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk